The DOI matches its Crossref record; 25 of the 27 references it cites were found in a registry or an index.
The Brief Assessment of Cognition in Schizophrenia: reliability, sensitivity, and comparison with a standard neurocognitive battery
Abstract
Studies of neurocognitive function in patients with schizophrenia use widely variable assessment techniques. Clinical trials assessing the cognitive enhancing effect of new medications have used neurocognitive assessment batteries that differed in content, length and administration procedures. The Brief Assessment of Cognition in Schizophrenia (BACS) is a newly developed instrument that assesses the aspects of cognition found to be most impaired and most strongly correlated with outcome in patients with schizophrenia. The BACS requires less than 35 min to complete in patients with schizophrenia, yields a high completion rate in these patients, and has high reliability. The BACS was found to be as sensitive to cognitive impairment in patients with schizophrenia as a standard battery of tests that required over 2 h to administer. Compared to healthy controls matched for age and parental education, patients with schizophrenia performed 1.49 standard deviations lower on a composite score calculated from the BACS and 1.61 standard deviations lower on a composite score calculated from the standard battery. The BACS composite scores were highly correlated with the standard battery composite scores in patients (r=0.76) and healthy controls (r=0.90). These psychometric properties make the BACS a promising tool for assessing cognition repeatedly in patients with schizophrenia, especially in clinical trials of cognitive enhancement.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Our search revealed the use of neuropsychological test batteries other than the MCCB (eg, BACS,23 CANTAB,24 and CSSB25), though their use is somewhat limited in the ongoing trials.”
From Clinical trials of potential cognitive-enhancing drugs in schizophrenia: what have we learned so far? (2013) · cites this paper as [23]
Citations
Cites
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
A new rating scale for Alzheimer's disease
(1984) · American Journal of Psychiatry · doi:10.1176/ajp.141.11.1356 · Cited by 4,175
What are the functional consequences of neurocognitive deficits in schizophrenia?
(1996) · American Journal of Psychiatry · doi:10.1176/ajp.153.3.321 · Cited by 3,516
Green, M. F., Kern, R. S., Braff, D. L., & Mintz, J. (2000) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a033430 · Cited by 2,999
(1995) · Cited by 2,809
Neurocognitive deficit in schizophrenia: A quantitative review of the evidence.
Heinrichs, R. W., & Zakzanis, K. K. (1998) · Neuropsychology · doi:10.1037/0894-4105.12.3.426 · Cited by 2,798
Neuropsychological Function in Schizophrenia
Saykin, A. J. (1991) · Archives of General Psychiatry · doi:10.1001/archpsyc.1991.01810310036007 · Cited by 1,160
Auditory Working Memory and Wisconsin Card Sorting Test Performance in Schizophrenia
Gold, J. M. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830140071013 · Cited by 823
Impaired Attention, Genetics, and the Pathophysiology of Schizophrenia
Cornblatt, B. A., & Keilp, J. G. (1994) · Schizophrenia Bulletin · doi:10.1093/schbul/20.1.31 · Cited by 666
Studies of Cognitive Change in Patients With Schizophrenia Following Novel Antipsychotic Treatment
Harvey, P. D., & Keefe, R. S. E. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.2.176 · Cited by 617
Flagged first, then by citations
2 of the 27 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 501–600 of 1,000
Takahashi, T., Tsugawa, S., Nakajima, S., Plitman, E., Chakravarty, M. M., Masuda, F., Wada, M., Kurose, S., Ochi, R., Matsushita, K., et al. (2020) · Schizophrenia Research · doi:10.1016/j.schres.2020.04.016 · Cited by 26
Mazhari, S., Parvaresh, N., Shahrbabaki, M. E., Sadeghi, M., Nakhaee, N., & Keefe, R. S. E. (2013) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12107 · Cited by 26
Comparing predictors of employment in Individual Placement and Support: A longitudinal analysis
Metcalfe, J. D., Riley, J., McGurk, S., Hale, T., Drake, R. E., & Bond, G. R. (2018) · Psychiatry Research · doi:10.1016/j.psychres.2018.03.050 · Cited by 25
Luther, L., Fischer, M. W., Johnson-Kwochka, A. V., Minor, K. S., Holden, R. J., Lapish, C. C., McCormick, B. P., & Salyers, M. P. (2020) · Journal of Consulting and Clinical Psychology · doi:10.1037/ccp0000599 · Cited by 29
MacNeill, L. A., Allen, N. B., Poleon, R. B., Vargas, T., Osborne, K. J., Damme, K. S. F., Barch, D. M., Krogh‐Jespersen, S., Nielsen, A. N., Norton, E. S., et al. (2021) · Development and Psychopathology · doi:10.1017/s0954579421000651 · Cited by 25
Barone, A., Prisco, M. D., Altavilla, B., Avagliano, C., Balletta, R., Buonaguro, E. F., Ciccarelli, M., D’Ambrosio, L., Giordano, S., Latte, G., et al. (2022) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2022.09.044 · Cited by 25
Ohmuro, N., Matsumoto, K., Katsura, M., Obara, C., Kikuchi, T., Hamaie, Y., Sakuma, A., Iizuka, K., Ito, F., & Matsuoka, H. (2015) · Schizophrenia Research · doi:10.1016/j.schres.2015.01.008 · Cited by 25
Hori, H., Yoshimura, R., Katsuki, A., Hayashi, K., Ikenouchi, A., Umene‐Nakano, W., & Nakamura, J. (2011) · International Journal of Psychiatry in Clinical Practice · doi:10.3109/13651501.2011.631018 · Cited by 25
Assisted Cycling Therapy (ACT) improves inhibition in adolescents with autism spectrum disorder
Ringenbach, S. D. R., Lichtsinn, K. C., & Holzapfel, S. D. (2015) · Journal of Intellectual & Developmental Disability · doi:10.3109/13668250.2015.1080352 · Cited by 27
Ikezawa, S., Mogami, T., Hayami, Y., Sato, I., Kato, T., Kimura, I., Pu, S., Kaneko, K., & Nakagome, K. (2011) · Psychiatry Research · doi:10.1016/j.psychres.2011.07.020 · Cited by 25
Nishinaka, H., Nakane, J., Nagata, T., Imai, A., Kuroki, N., Sakikawa, N., Omori, M., Kuroda, O., Hirabayashi, N., Igarashi, Y., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0148354 · Cited by 25
Matsuda, Y., Morimoto, T., Furukawa, S., Sato, S., Hatsuse, N., Iwata, K., Kimura, M., Kishimoto, T., & Ikebuchi, E. (2016) · Neuropsychological Rehabilitation · doi:10.1080/09602011.2016.1181555 · Cited by 25
Romero, Y. R., KEIL, J. E., Balz, J., Gallinat, J., & Senkowski, D. (2016) · Journal of Neurophysiology · doi:10.1152/jn.00096.2016 · Cited by 23
Wang, L., Lin, P., Lee, Y., Huang, Y., Wu, C., Hsu, S., Chen, C.-C., Chong, M., Lin, C., & Hung, C. (2017) · Schizophrenia Research · doi:10.1016/j.schres.2017.03.041 · Cited by 25
Takahashi, T., Nakamura, M., Sasabayashi, D., Komori, Y., Higuchi, Y., Nishikawa, Y., Nishiyama, S., Itoh, H., Masaoka, Y., & Suzuki, M. (2017) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-017-0845-3 · Cited by 25
Kraus, M., Walker, T. M., Jarskog, L. F., Millet, R. A., & Keefe, R. S. E. (2018) · Schizophrenia Research · doi:10.1016/j.schres.2018.08.031 · Cited by 28
Almulla, A. F., Al‐Hakeim, H. K., Abed, M. S., Carvalho, A. F., & Maes, M. H. J. (2020) · Schizophrenia Research · doi:10.1016/j.schres.2020.05.003 · Cited by 25
Tobe, M., Nemoto, T., Tsujino, N., Yamaguchi, T., Katagiri, N., Fujii, C., & Mizuno, M. (2015) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2015.10.006 · Cited by 29
Cognitive Screening in Persons With Chronic Diseases in Primary Care
Athilingam, P. R., Visovsky, C. M., Elliott, A., & Rogal, P. J. (2015) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317515577127 · Cited by 24
Implementation considerations for multisite clinical trials with cognitive neuroscience tasks
Keefe, R. S. E., & Harvey, P. D. (2007) · Schizophrenia Bulletin · doi:10.1093/schbul/sbn042 · Cited by 24
Emotional Intelligence deficits in schizophrenia: The impact of non-social cognition
Frajo-Apor, B., Pardeller, S., Kemmler, G., Welte, A.-S., & Hofer, A. (2016) · Schizophrenia Research · doi:10.1016/j.schres.2016.02.027 · Cited by 24
Najas-García, A., Gómez‐Benito, J., & Huedo-Medina, T. B. (2018) · Community Mental Health Journal · doi:10.1007/s10597-018-0266-4 · Cited by 29
Comprehensive review of the research employing the schizophrenia cognition rating scale (SCoRS)
Harvey, P. D., Khan, A., Atkins, A. S., Walker, T. M., & Keefe, R. S. E. (2019) · Schizophrenia Research · doi:10.1016/j.schres.2019.05.040 · Cited by 24
Mousa, R. F., Al‐Hakeim, H. K., Alhaideri, A. F., & Maes, M. H. J. (2020) · Metabolic Brain Disease · doi:10.1007/s11011-020-00619-x · Cited by 23
Zhou, C., & Li, Z. (2020) · Journal of Clinical Nursing · doi:10.1111/jocn.15407 · Cited by 23
Cognitive decline and impairment in schizophrenia spectrum disorders reconsidered
Parlar, M. E., & Heinrichs, R. W. (2020) · Schizophrenia Research · doi:10.1016/j.schres.2020.11.020 · Cited by 24
Haddad, C., Salameh, P., Hallit, S. R., Obeïd, S., Haddad, G., Clément, J., & Calvet, B. (2021) · BMC Psychiatry · doi:10.1186/s12888-021-03228-9 · Cited by 24
Guerin, A. A., Drummond, K. D., Bonomo, Y. A., Lawrence, A. J., Rossell, S. L., & Kim, J. H. (2021) · Addictive Behaviors · doi:10.1016/j.addbeh.2021.107075 · Cited by 25
Zhang, T., Wang, J., Xu, L., Wei, Y., Tang, X., Hu, Y., Cui, H., Tang, Y., Li, C., Zheng, L., et al. (2021) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-021-01331-2 · Cited by 24
Effect of antipsychotic dose reduction on cognitive function in schizophrenia
Singh, A., Kumar, V., Pathak, H., Jacob, A., Venkatasubramanian, G., Varambally, S. S., & Rao, N. P. (2022) · Psychiatry Research · doi:10.1016/j.psychres.2021.114383 · Cited by 24
Ohi, K., Nishizawa, D., Sugiyama, S., Takai, K., Fujikane, D., Kuramitsu, A., Hasegawa, J., Soda, M., Kitaichi, K., Hashimoto, R., et al. (2022) · Psychological Medicine · doi:10.1017/s0033291722001271 · Cited by 26
Sørensen, N. V., Borbye‐Lorenzen, N., Christensen, R. H. B., Orlovska‐Waast, S., Jeppesen, R., Skogstrand, K., & Benros, M. E. (2023) · Journal of Neuroinflammation · doi:10.1186/s12974-023-02757-2 · Cited by 25
Krčmář, L., Jäger, I. M., Boudriot, E., Hanken, K., Gabriel, V., Melcher, J., Klimas, N., Dengl, F., Schmölz, S., Pingen, P., et al. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1179811 · Cited by 23
Lizano, P. L., Kiely, C., Mijalkov, M., Meda, S. A., Keedy, S., Hoang, D. T., Zeng, V., Lutz, O., Pereira, J. B., Ivleva, E. I., et al. (2023) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2023.07.014 · Cited by 24
Dowell-Esquivel, C., Czaja, S. J., Kallestrup, P., Depp, C. A., Saber, J. N., & Harvey, P. D. (2023) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2023.10.014 · Cited by 25
Chia, M. Y., Chan, W. Y., Chua, K. Y., Lee, H. Y., Lee, J., Lee, R., Lim, C., Tay, E., Woon, P. S., Keefe, R. S. E., et al. (2010) · Psychiatry Research · doi:10.1016/j.psychres.2010.03.020 · Cited by 24
Antipsychotic agents: efficacy and safety in schizophrenia
de Sena, E. P., Araújo, de Oliveira, I., & Juruena, M. F. (2012) · Drug Healthcare and Patient Safety · doi:10.2147/dhps.s37429 · Cited by 26
Buonocore, M., Bosia, M., Riccaboni, R., Bechi, M., Spangaro, M., Piantanida, M., Cocchi, F., Guglielmino, C., Bianchi, L., Smeraldi, E., et al. (2015) · European Psychiatry · doi:10.1016/j.eurpsy.2015.02.006 · Cited by 25
Investigation of clinical factors influencing cognitive function in Japanese schizophrenia
Kishi, T., Moriwaki, M., Kawashima, K., Okochi, T., Fukuo, Y., Kitajima, T., Furukawa, O., Naitoh, H., Fujita, K., & Iwata, N. (2009) · Neuroscience Research · doi:10.1016/j.neures.2009.12.007 · Cited by 24
Ishøy, P. L., Knop, F. K., Broberg, B. V., Baandrup, L., Fagerlund, B., Jørgensen, N. R., Andersen, U. B., Rostrup, E., Glenthoj, B. Y., & Ebdrup, B. H. (2014) · BMJ Open · doi:10.1136/bmjopen-2013-004158 · Cited by 24
Reliability and Validity of The Turkish Version of Cognitive Assessment Interview (CAI-TR)
Boşgelmez, Ş., Yıldız, M., Yazıcı, E., İnan, E., Turgut, C., Karabulut, U., Kırcalı, A., Taş, H. İ., Yakisir, S. S., Çakır, U., et al. (2015) · Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology · doi:10.5455/bcp.20150502064017 · Cited by 27
Simvastatin augmentation for recent-onset psychotic disorder: A study protocol
Begemann, M., Schutte, M. J. L., Slot, M. I. E., Doorduin, J., Bakker, P. R., van Haren, N. E. M., & Sommer, I. E. (2015) · BBA Clinical · doi:10.1016/j.bbacli.2015.06.007 · Cited by 24
Emotional intelligence and non-social cognition in schizophrenia and bipolar I disorder
Frajo-Apor, B., Kemmler, G., Pardeller, S., Plass, T., Mühlbacher, M., Welte, A., Fleischhacker, W. W., & Hofer, A. (2016) · Psychological Medicine · doi:10.1017/s0033291716002324 · Cited by 24
Hidese, S., Hattori, K., Sasayama, D., Miyakawa, T., Matsumura, R., Yokota, Y., Ishida, I., Matsuo, J., Noda, T., Yoshida, S., et al. (2017) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.02.016 · Cited by 24
Buonocore, M., Bosia, M., Baraldi, M. A., Bechi, M., Spangaro, M., Cocchi, F., Bianchi, L., Guglielmino, C., Mastromatteo, A. R., & Cavallaro, R. (2017) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12605 · Cited by 24
Themes of unfulfilled agency and communion in life stories of patients with schizophrenia
Holm, T., Thomsen, D. K., & Bliksted, V. (2018) · Psychiatry Research · doi:10.1016/j.psychres.2018.08.116 · Cited by 26
Clinical correlates associated with cognitive dysfunction in people with schizophrenia
Tanaka, T., Tomotake, M., Ueoka, Y., Kaneda, Y., Taniguchi, K., Nakataki, M., Numata, S., Tayoshi, S., Yamauchi, K., Sumitani, S., et al. (2012) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.2012.02390.x · Cited by 24
Stone, W. S., Mesholam‐Gately, R. I., Giuliano, A. J., Woodberry, K. A., Addington, J., Bearden, C. E., Cadenhead, K. S., Cannon, T. D., Cornblatt, B. A., Mathalon, D. H., et al. (2016) · Schizophrenia Research · doi:10.1016/j.schres.2016.02.003 · Cited by 24
Alloza, C., Cox, S. R., Duff, B. J., Semple, S. I. K., Bastin, M. E., Whalley, H. C., & Lawrie, S. M. (2016) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2016.05.008 · Cited by 24
Towards a framework for treatment effectiveness in schizophrenia
Juckel, G., de Bartolomeis, A., Gorwood, P. A. P. M., Mosolov, S. N., Pani, L., Rossi, A., & Sanjuán, J. (2014) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s61672 · Cited by 23
Moustafa, S. R., Al-Rawi, K. F., Stoyanov, D., Al-Dujaili, A. H., Supasitthumrong, T., Al‐Hakeim, H. K., & Maes, M. H. J. (2020) · Diagnostics · doi:10.3390/diagnostics10090633 · Cited by 23
Cognitive Impairments of Sleep-Deprived Ovariectomized (OVX) Female Rats by Voluntary Exercise
Rajizadeh, M. A., Esmaeilpour, K., Motamedy, S., Borzadaran, F. M., & Sheibani, V. (2020) · Basic and Clinical Neuroscience Journal · doi:10.32598/bcn.9.10.505 · Cited by 26
Zhang, L., Lizano, P. L., Guo, B., Xu, Y., Rubin, L. H., Hill, S. K., Alliey‐Rodriguez, N., Lee, A. M., Wu, B., Keedy, S., et al. (2022) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2022.100459 · Cited by 24
Atkins, A. S., Kraus, M., Welch, M., Yuan, Z., Stevens, H. B., Welsh-Bohmer, K. A., & Keefe, R. S. E. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.910896 · Cited by 23
Al‐Hakeim, H. K., Al-Musawi, A. F., Almulla, A. F., Al-Dujaili, A. H., Debnath, M., & Maes, M. H. J. (2022) · PLoS ONE · doi:10.1371/journal.pone.0275839 · Cited by 26
Czaja, S. J., Kallestrup, P., & Harvey, P. D. (2024) · Innovation in Aging · doi:10.1093/geroni/igae065 · Cited by 24
Schott, B. H., Voss, M., Wagner, B., Wüstenberg, T., Düzel, E., & Behr, J. (2015) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2015.00144 · Cited by 23
Developing therapeutics for schizophrenia and other psychotic disorders
Marek, G. J., & Merchant, K. (2005) · NeuroRx · doi:10.1602/neurorx.2.4.579 · Cited by 22
Luria revisited: cognitive research in schizophrenia, past implications and future challenges
Zaytseva, Y., Chan, R. C. K., Pöppel, E., & Heinz, A. (2015) · Philosophy Ethics and Humanities in Medicine · doi:10.1186/s13010-015-0026-9 · Cited by 28
Facial expression perception correlates with verbal working memory function in schizophrenia
Hagiya, K., Sumiyoshi, T., Kanie, A., Pu, S., Kaneko, K., Mogami, T., Oshima, S., Niwa, S., Inagaki, A., Ikebuchi, E., et al. (2015) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12329 · Cited by 23
Brunette, M. F., Ferron, J. C., Gottlieb, J. D., Devitt, T. S., & Rotondi, A. J. (2016) · Internet Interventions · doi:10.1016/j.invent.2016.05.003 · Cited by 24
Itakura, M., Pu, S., Ohdachi, H., Matsumura, H., Yokoyama, K., Nagata, I., Iwata, M., & Kaneko, K. (2017) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12548 · Cited by 23
Buonocore, M., Bechi, M., Uberti, P., Spangaro, M., Cocchi, F., Guglielmino, C., Bianchi, L., Mastromatteo, A. R., Bosia, M., & Cavallaro, R. (2018) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617718000012 · Cited by 23
Yang, Z., Lim, K., Lam, M., Keefe, R., & Lee, J. (2018) · Schizophrenia Research · doi:10.1016/j.schres.2018.05.024 · Cited by 26
Chen, C.-Y., Wu, C., Huang, Y., Hung, C., & Wang, L. (2018) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s176047 · Cited by 23
Negative and positive self-thoughts predict subjective quality of life in people with schizophrenia
Takeda, T., Nakataki, M., Ohta, M., Hamatani, S., Matsuura, K., Yoshida, R., Kameoka, N., Tominaga, T., Umehara, H., Kinoshita, M., et al. (2019) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s190381 · Cited by 18
Caponnetto, P., Polosa, R., Robson, D., & Bauld, L. (2020) · Health Psychology Research · doi:10.4081/hpr.2020.9042 · Cited by 24
Luo, C., Lencer, R., Hu, N., Xiao, Y., Zhang, W., Li, S., Lui, S., & Gong, Q. (2020) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyaa061 · Cited by 23
Mascio, A., Stewart, R. J., Botelle, R., Williams, M., Mirza, L., Patel, R., Pollak, T. A., Dobson, R., & Roberts, A. (2021) · Frontiers in Digital Health · doi:10.3389/fdgth.2021.711941 · Cited by 27
Distinct Volume Alterations of Thalamic Nuclei Across the Schizophrenia Spectrum
Thalhammer, M., Schulz, J., Scheulen, F., Oubaggi, M. E. M., Kirschner, M., Kaiser, S., Schmidt, A., Borgwardt, S., Avram, M., Brandl, F., et al. (2024) · Schizophrenia Bulletin · doi:10.1093/schbul/sbae037 · Cited by 21
Sumiyoshi, T., Miyanishi, T., Seo, T., & Higuchi, Y. (2013) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2013.00148 · Cited by 22
Frajo-Apor, B., Pardeller, S., Kemmler, G., & Hofer, A. (2015) · Psychology Health & Medicine · doi:10.1080/13548506.2015.1120325 · Cited by 22
Ramsay, I. S., Schallmo, M., Biagianti, B., Fisher, M., Vinogradov, S., & Sponheim, S. R. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00638 · Cited by 21
Friedman‐Yakoobian, M. S., Parrish, E. M., Eack, S. M., & Keshavan, M. S. (2020) · Schizophrenia Research · doi:10.1016/j.schres.2020.09.005 · Cited by 22
Schmid, P., Czekaj, A., Frick, J., Steinert, T., Purdon, S. E., & Uhlmann, C. (2021) · BMC Psychiatry · doi:10.1186/s12888-021-03508-4 · Cited by 22
Harvey, P. D., Zayas-Bazan, M., Tibiriçá, L., Kallestrup, P., & Czaja, S. J. (2021) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2021.11.008 · Cited by 23
Dombi, Z. B., Szendi, I., & Burnet, P. W. J. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.827322 · Cited by 23
Current and Emergent Treatments for Symptoms and Neurocognitive Impairment in Schizophrenia
Javitt, D. C. (2014) · Current Treatment Options in Psychiatry · doi:10.1007/s40501-014-0010-9 · Cited by 23
Kaneda, Y. (2009) · Clinical Neuropharmacology · doi:10.1097/wnf.0b013e3181b130a0 · Cited by 22
Steadman, J., Pawlby, S. J., Mayers, A., Bucks, R. S., Grégoire, A., Miele‐Norton, M., & Hogan, A. M. (2007) · Journal of Reproductive and Infant Psychology · doi:10.1080/02646830701691343 · Cited by 22
Kashiwagi, H., Kuroki, N., Ikezawa, S., Matsushita, M., Ishikawa, M., Nakagome, K., Hirabayashi, N., & Ikeda, M. (2015) · Annals of General Psychiatry · doi:10.1186/s12991-015-0086-7 · Cited by 22
Krukow, P., Szaniawska, O., Harciarek, M., Plechawska–Wójcik, M., & Jonak, K. (2017) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.12.050 · Cited by 22
Understanding software developers' cognition in agile requirements engineering
Jia, J., Yang, X., Zhang, R., & Liu, X. (2019) · Science of Computer Programming · doi:10.1016/j.scico.2019.03.005 · Cited by 22
Assessing Cognition Outside of the Clinic
Hays, R., Henson, P., Wisniewski, H., Hendel, V., Vaidyam, A. N., & Torous, J. B. (2019) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2019.08.003 · Cited by 22
Pu, S., Nakagome, K., Itakura, M., Iwata, M., Nagata, I., & Kaneko, K. (2016) · Schizophrenia Research · doi:10.1016/j.schres.2016.01.045 · Cited by 22
Tso, I. F., Calwas, A. M., Chun, J., Mueller, S. A., Taylor, S. F., & Deldin, P. J. (2015) · Journal of Abnormal Psychology · doi:10.1037/abn0000056 · Cited by 25
Noda, T., Nakagome, K., Setoyama, S., & Matsushima, E. (2017) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2017.09.001 · Cited by 22
The role of cannabidiol oil in schizophrenia treatment. a systematic review and meta-analysis
Kopelli, E., Samara, M. T., Siargkas, A., Goulas, A., Papazisis, G., & Chourdakis, M. (2020) · Psychiatry Research · doi:10.1016/j.psychres.2020.113246 · Cited by 21
Guimond, S., Gu, F., Shannon, H., Kelly, S., Mike, L., Devenyi, G. A., Chakravarty, M. M., Sweeney, J. A., Pearlson, G. D., Clementz, B. A., et al. (2021) · Schizophrenia Bulletin · doi:10.1093/schbul/sbab071 · Cited by 21
Semantic and phonetic similarity of verbal fluency responses in early-stage psychosis
Lundin, N. B., Jones, M. N., Myers, E. J., Breier, A. F., & Minor, K. S. (2022) · Psychiatry Research · doi:10.1016/j.psychres.2022.114404 · Cited by 21
Manchia, M., Isayeva, U., Collu, R., Primavera, D., Deriu, L., Caboni, E., Iaselli, M. N., Sundas, D., Tusconi, M., Pinna, F., et al. (2022) · Brain Sciences · doi:10.3390/brainsci12121666 · Cited by 20
Impact of Cognitive Impairments on Health-Related Quality of Life in Schizophrenia
Rekhi, G., Saw, Y. E., Lim, K., Keefe, R. S. E., & Lee, J. (2023) · Brain Sciences · doi:10.3390/brainsci13020215 · Cited by 21
Jones, S. E., & Harvey, P. D. (2023) · Translational Psychiatry · doi:10.1038/s41398-023-02400-x · Cited by 22
Scheurink, T. A. W., Borkent, J., Gangadin, S. S., Aidy, S. E., Mandl, R. C. W., & Sommer, I. E. (2023) · Brain and Behavior · doi:10.1002/brb3.3011 · Cited by 19
Choroid plexus volume enlargement in first-episode antipsychotic-naïve schizophrenia
Zeng, J., Zhang, T., Tang, B., Li, S., Li, Y., Bishop, J. R., Sweeney, J. A., Li, Z., Qiu, C., Gu, S., et al. (2024) · Schizophrenia · doi:10.1038/s41537-023-00424-2 · Cited by 21
Hou, W., Zhou, F., Wang, Q., Li, H., Qin, X., Ding, Y., Dong, F., Bo, Q., Li, A., Zhang, L., et al. (2024) · Translational Psychiatry · doi:10.1038/s41398-024-02994-w · Cited by 21
Deconstructing Schizophrenia forDSM-V: Challenges for Clinical and Research Agendas
Pierre, J. M. (2008) · Clinical Schizophrenia & Related Psychoses · doi:10.3371/csrp.2.2.8 · Cited by 21
Tek, C., Gülöksüz, S., Srihari, V. H., & Reutenauer, E. L. (2013) · BMC Psychiatry · doi:10.1186/1471-244x-13-176 · Cited by 21
Son, S., Kubota, M., Miyata, J., Fukuyama, H., Aso, T., Urayama, S., Murai, T., & Takahashi, H. (2015) · Schizophrenia Research · doi:10.1016/j.schres.2015.03.009 · Cited by 25
Nemoto, T., Uchino, T., Aikawa, S., Saito, J., Matsumoto, H., Funatogawa, T., Yamaguchi, T., Katagiri, N., Tsujino, N., & Mizuno, M. (2019) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12848 · Cited by 21
Metadata
- Authors
- Keefe, R.
- Affiliations
- Duke University (US)
- Corresponding author
- Keefe, R
- ORCID
- Keefe, R
- Venue
- Schizophrenia Research
- Publisher
- Elsevier BV
- Published
- 2004-06-01
- Volume
- 68
- Issue
- 2-3
- Pages
- 283-297
- ISSN
- 0920-9964 (ISSN-L)
- OpenAlex
- W2008062633
- Cited by
- 1,573
- References
- 27
- Citations by year
- 2026: 100 · 2025: 129 · 2024: 115 · 2023: 96 · 2022: 107 · 2021: 130 · 2020: 129 · 2019: 105 · 2018: 90 · 2017: 89 · 2016: 83 · 2015: 82 · 2014: 62 · 2013: 65 · 2012: 44
- FWCI
- 4.09
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Schizophrenia Research (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Social Sciences › Psychology › Applied Psychology › Psychological Testing and Assessment
- Social Sciences › Arts and Humanities › Philosophy › Mental Health and Psychiatry
- Keywords
- Brief Assessment of Cognition in Schizophrenia, schizophrenia
- MeSH terms
- Adult, Clinical Trials as Topic, Cognition Disorders, Female, Humans, Male, Neuropsychological Tests, Practice, Psychological, Psychometrics, Research Design, Schizophrenia, Schizophrenic Psychology, Sensitivity and Specificity, Antipsychotic Agents, Reproducibility of Results
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review